Scarica l'app Stockscreener
7.46
2.93%
-0.225
Dopo l'orario di chiusura:
7.35
-0.11
-1.47%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$7.685
Aprire:
$7.53
Volume 24 ore:
31,127
Relative Volume:
0.01
Capitalizzazione di mercato:
$16.70M
Reddito:
$74,000
Utile/perdita netta:
$-13.43M
Rapporto P/E:
-0.7936
EPS:
-9.4
Flusso di cassa netto:
$-10.54M
1 W Prestazione:
-4.60%
1M Prestazione:
-23.96%
6M Prestazione:
+42.58%
1 anno Prestazione:
-56.01%
Intervallo 1D:
$7.26
$7.59
Intervallo di 1 settimana:
$7.26
$8.82
Portata 52W:
$0.215
$39.84
Cyclacel Pharmaceuticals Inc Stock (CYCC) Company Profile
Nome
Cyclacel Pharmaceuticals Inc
Settore
Industria
Telefono
908-517-7330
Indirizzo
200 CONNELL DRIVE, BERKELEY HEIGHTS, NJ
Confronta CYCC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CYCC
Cyclacel Pharmaceuticals Inc
|
7.46 | 17.22M | 74,000 | -13.43M | -10.54M | -9.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Cyclacel Pharmaceuticals Inc Stock (CYCC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-07-18 | Ripresa | Oppenheimer | Outperform |
| 2020-04-27 | Ripresa | ROTH Capital | Buy |
| 2018-09-07 | Iniziato | Ladenburg Thalmann | Buy |
| 2015-10-16 | Iniziato | H.C. Wainwright | Buy |
| 2010-02-04 | Iniziato | Roth Capital | Buy |
| 2009-10-28 | Iniziato | Merriman | Buy |
| 2008-08-12 | Iniziato | Piper Jaffray | Buy |
| 2008-03-12 | Reiterato | Cantor Fitzgerald | Buy |
| 2008-03-12 | Reiterato | Collins Stewart | Buy |
| 2008-03-12 | Reiterato | Needham & Co | Buy |
| 2007-11-27 | Reiterato | Cantor Fitzgerald | Buy |
| 2007-08-10 | Reiterato | Cantor Fitzgerald | Buy |
| 2007-06-04 | Reiterato | Needham & Co | Buy |
| 2007-04-23 | Iniziato | Lazard Capital | Buy |
| 2007-04-10 | Iniziato | Cantor Fitzgerald | Buy |
Mostra tutto
Cyclacel Pharmaceuticals Inc Borsa (CYCC) Ultime notizie
What are Cyclacel Pharmaceuticals Inc.’s earnings expectationsMarket Movers & Expert Approved Trade Ideas - khodrobank.com
Using R and stats models for Cyclacel Pharmaceuticals Inc. forecastingAnalyst Downgrade & Smart Allocation Stock Tips - Newser
Is Cyclacel Pharmaceuticals Inc. still a buy after recent gainsJuly 2025 Sector Moves & Daily Volume Surge Trade Alerts - khodrobank.com
Is Cyclacel Pharmaceuticals Inc. stock entering bullish territoryChart Signals & Consistent Profit Alerts - Newser
Has Cyclacel Pharmaceuticals Inc. formed a bullish divergenceWeekly Profit Analysis & AI Forecasted Stock Moves - Newser
Is a relief rally coming for Cyclacel Pharmaceuticals Inc. holdersMarket Risk Analysis & Consistent Profit Trading Strategies - Newser
Quantitative breakdown of Cyclacel Pharmaceuticals Inc. recent moveExit Point & Weekly Watchlist of Top Performers - Newser
Why Cyclacel Pharmaceuticals Inc. stock attracts strong analyst attentionM&A Rumor & AI Optimized Trade Strategies - Newser
Is Cyclacel Pharmaceuticals Inc. stock poised for growthQuarterly Growth Report & Weekly High Return Opportunities - Newser
How cyclical is Cyclacel Pharmaceuticals Inc.’s revenue streamJuly 2025 Outlook & Community Verified Watchlist Alerts - khodrobank.com
Top chart patterns to watch in Cyclacel Pharmaceuticals Inc.Market Movement Recap & Consistent Profit Trade Alerts - Newser
Is Cyclacel Pharmaceuticals Inc. stock risky to hold nowEarnings Growth Summary & Weekly High Conviction Trade Ideas - khodrobank.com
Real time scanner hits for Cyclacel Pharmaceuticals Inc. explainedWeekly Investment Report & Verified Swing Trading Watchlist - Newser
What high frequency data says about Cyclacel Pharmaceuticals Inc.Trade Analysis Summary & Weekly Market Pulse Updates - Newser
Market reaction to Cyclacel Pharmaceuticals Inc.’s recent newsWeekly Market Summary & Target Return Focused Stock Picks - Newser
News impact scoring models applied to Cyclacel Pharmaceuticals Inc.Oil Prices & Free Technical Pattern Based Buy Signals - Newser
Cyclacel Pharmaceuticals Amends Stock Purchase Warrants - TipRanks
Cyclacel Pharmaceuticals : Initial Statement of Beneficial Ownership (Form 3) - MarketScreener
When is the best time to exit Cyclacel Pharmaceuticals Inc.Trade Exit Summary & Verified Chart Pattern Trade Signals - Newser
Can Cyclacel Pharmaceuticals Inc. hit a new high this month2025 Momentum Check & Free Expert Verified Stock Movement Alerts - Newser
Is Cyclacel Pharmaceuticals Inc. stock trending bullishIPO Watch & Weekly Return Optimization Alerts - khodrobank.com
Is Cyclacel Pharmaceuticals Inc. affected by consumer sentimentQuarterly Earnings Report & Daily Chart Pattern Signals - khodrobank.com
Is Cyclacel Pharmaceuticals Inc. gaining market shareJuly 2025 Institutional & Fast Moving Stock Trade Plans - khodrobank.com
Signal strength of Cyclacel Pharmaceuticals Inc. stock in tech scannersJuly 2025 Fed Impact & Real-Time Market Trend Scan - Newser
Tools to monitor Cyclacel Pharmaceuticals Inc. recovery probabilityJuly 2025 News Drivers & Verified Swing Trading Watchlist - Newser
What moving averages say about Cyclacel Pharmaceuticals Inc.July 2025 Market Mood & Verified Technical Trade Signals - Newser
Using fundamentals and technicals on Cyclacel Pharmaceuticals Inc.Weekly Market Outlook & Free Weekly Chart Analysis and Trade Guides - Newser
Price momentum metrics for Cyclacel Pharmaceuticals Inc. explainedQuarterly Portfolio Report & Stepwise Trade Signal Implementation - Newser
Cyclacel Pharmaceuticals Inc Azioni (CYCC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Cyclacel Pharmaceuticals Inc Azioni (CYCC) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Lazar David E. | Interim CEO |
Feb 26 '25 |
Sale |
0.03 |
194,628,820 |
5,507,996 |
0 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):